Proton Pump Inhibitor
From Anvita Health Wiki
Contents |
More Specific Terms
- dexlansoprazole (Kapidex, Dexilant)
- lansoprazole (Prevacid)
- omeprazole (Prilosec, Zegerid, Losec, Medral)
- pantoprazole (Protonix)
- rabeprazole (Aciphex)
Indications
- peptic ulcer [5]; more effective than H2 blockers
- short-term treatment of severe erosive esophagitis
- short-term treatment of gastroesophageal reflux disease
- pathologic hypersecretory conditions
- long-term antiplatelet therapy if: [7]
- history of peptic ulcer or gastrointestinal bleeding
- dual antiplatelet therapy or concomitant anticoagulation
- additional risk factors (age >= 60, steroid use, dyspepsia, or gastroesophageal reflux)
Contraindications
- probably not indicated for routine treatment of asthma [9]
- probably overprescribed [14]
- not effective in infants [16]; may be effective in children & adolescents
Dosage
- (administration)
- administer in AM, 20-45 minutes before 1st meal
- pantoprazole ( Protonix) available for IV injection
- omeprazole may be available for IV injection
Pharmacokinetics
- bioavailability 35-90%
- highly protein bound (90-97%)
- rapidly metabolized in the liver ( cyt P450)
- elimination 1/2life of 1-1.5 hours
- duration of acid inhibition: 48-72 hours
Adverse-effects
- increased risk of C difficile colitis [4,17]
- increased risk of nosocomial pneumonia (HR=2.5) [11,12]
- increased risk of spontaneous bacterial peritonitis in cirrhotic patients with ascites [10]
- rebound gastric hyperacidity may occur in patients when proton pump inhibitor is stopped after 2 months of use; best managed with antiacids [13]
- drug adverse effects of proton pump inhibitors
Mechanism-of-action
- covalent binding to cysteine residues of the H+/K+ ATPase ( proton pump)
- inhibition of the proton pump & gastric acid secretion
- esomeprazole (active stereoisomer of omeprazole) may be most effective PPI [3]
- more effecting than H2 blockers to peptic ulcer bleeding [5]
- PPIs don't provide continuous acid suppression... even with BID dosing - nighttime acid breakthrough occurs in > 70% of patients
- acid secretion triggered by histamine may not be effectively inhibited by proton pump inhibitors [6]
More General Terms
References
- The Pharmacological Basis of Therapeutics, 9th ed. Gilman et al, eds. Permagon Press/McGraw Hill, 1996
- Barkun A et al, Ann Intern Med 139:843, 2003 PMID: [1]
- Journal Watch 24(2):19, 2004 Miner P et al, Am J Gastroenterol 98:2616, 2003 PMID: [2]
- Prescriber's Letter 11(8): 2004 Proton Pump Inhibitors Associated with Increased Risk of Clostridium difficile Diarrhea Detail-Document#: [3] (subscription needed) [4]
- Journal Watch 25(10):80, 2005 Leontiadis GI, Sharma VK, Howden CW. Systematic review and meta-analysis of proton pump inhibitor therapy in peptic ulcer bleeding. BMJ. 2005 Mar 12;330(7491):568. Epub 2005 Jan 31. Review. <PubMed> PMID: [5] <Internet> [6]
- Prescriber's Letter 14(3): 2007 What You Should Know About Proton Pump Inhibitors Detail-Document#: [7] (subscription needed) [8]
- Prescriber's Letter 16(3): 2009 Comparison of Proton Pump Inhibitors Detail-Document#: [9] (subscription needed) [10]
- Bhatt DL et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol 2008 Nov; 103:2890.
- Bhatt DL et al, ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. PMID: &dopt=Abstract
- Bhatt DL et al. ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2008 Oct 28; 118:1894. PMID: [11] - Prescriber's Letter 16(6): 2009 Do Proton Pump Inhibitors (PPIs) Improve Asthma? Detail-Document#: [12] (subscription needed) [13]
- Bajaj JS et al Association of proton pump inhibitor therapy with spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterol 2009 May; 104:1130. PMID: [14]
- Herzig SJ et al, Acid-Suppressive Medication Use and the Risk for Hospital- Acquired Pneumonia JAMA. 2009;301(20):2120-2128 PMID: [15]
- Prescriber's Letter 16(7): 2009 Overuse of Acid Suppressing Drugs in the Hospital Detail-Document#: [16] (subscription needed) [17]
- Reimer C et al. Proton-pump inhibitor therapy induces acid-related symptoms in healthy volunteers after withdrawal of therapy. Gastroenterology 2009 Jul; 137:80. PMID: [18]
- McColl KEL and Gillen D. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat. Gastroenterology 2009 Jul; 137:20. PMID: [19] - Yachimski PS et al Proton Pump Inhibitors for Prophylaxis of Nosocomial Upper Gastrointestinal Tract Bleeding Arch Intern Med. 2010;170(9):779-783. <PubMed> PMID: [20] <Internet> [21]
- Katz MH Failing the Acid Test: Benefits of Proton Pump Inhibitors May Not Justify the Risks for Many Users Arch Intern Med. 2010;170(9):747-748. <PubMed> PMID: [22] <Internet> [23] - Prescriber's Letter 17(7): 2010 COMMENTARY: Proton Pump Inhibitors: Appropriate Use and Safety Concerns CHART: Comparison of Proton Pump Inhibitors PATIENT HANDOUT: What You Should Know About Proton Pump Inhibitors Detail-Document#: [24] (subscription needed) [25]
- van der Pol RJ et al. Efficacy of proton-pump inhibitors in children with gastroesophageal reflux disease: A systematic review. Pediatrics 2011 May; 127:925. PMID: [26]
- FDA MedWatch: 02/08/2012 Proton Pump Inhibitors (PPIs) - Drug Safety Communication: Clostridium Difficile-Associated Diarrhea (CDAD) Can be Associated With Stomach Acid Drugs [27]
